Apollomics Inc. (APLM)
Nasdaq: APLM · Pharmaceutical Preparations · Foster City, CA · filing with the SEC since 2022
Who owns Apollomics Inc.
As filed with the SECHolders of 5% or more
1
Hung-Wen Chen holds 49.8% of Class A ordinary shares, as its SCHEDULE 13D/A filed Aug 17, 2026 says.
Directors and officers
9
report now, of 9 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Hung-Wen Chen
SCHEDULE 13D/A · filed Aug 17, 2026 · Class A ordinary shares · 41.8% in Apr 6, 2026
Yi-Kuei Chen
SCHEDULE 13D/A · filed Aug 14, 2026 · Class A ordinary shares, par value $0.01 per share · reported falling below 5%, from 5.3% in Apr 8, 2026
Maxpro Investment Co., Ltd
SCHEDULE 13G/A · filed Sep 5, 2025 · Class A ordinary shares, Par Value $0.0001 per share · reported falling below 5%
Alpha Intelligence Enterprises Ltd
SCHEDULE 13G/A · filed Jan 10, 2025 · Class A ordinary shares, par value $0.0001 per share · reported falling below 5%
What APLM reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Maxpro Capital Acquisition Corp
A company bought · acquisition · owns, named in the 20-F filed Apr 24, 2026
6 subsidiaries in 4 countries, from the list filed with the 20-F filed Mar 28, 2024.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$8.3Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 9 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Chen Hung-Wen | Chief Executive Officer | 0 | $0 | 0 | 3 | $7.6M |
| Lin Peter Kuan-How | Chief Financial Officer | 0 | $0 | 0 | 1 | $400,000 |
| Chen Yi-Kuei | Chief Operating Officer | 0 | $0 | 0 | 1 | $300,000 |